Concurrent diagnosis of invasive or microinvasive breast cancer in either breast
Current diagnosis of bilateral breast cancer
History of radiotherapy for current breast cancer diagnosis
Diagnosis of breast malignancy
Subjects must not have received any other breast cancer-specific therapy for the current breast cancer diagnosis prior to registration
Patients should have a life expectancy of at least  years, excluding their diagnosis of breast cancer; (comorbid conditions should be taken into consideration, but not the diagnosis of breast cancer)
diagnosis of HR+, HER+ breast cancer (BC)
Proven diagnosis of metastatic breast cancer (MBC).
Confirmed diagnosis of HR+/HER- breast cancer
History of invasive breast cancer prior to the current diagnosis
Have a diagnosis of HR+, HER- breast cancer.
Have a diagnosis of HR+, HER- breast cancer
Current diagnosis of bilateral breast cancer
Current diagnosis of any other active or clinically significant non-breast cancer
Have a diagnosis of breast cancer and be chemotherapy naive; NOTE: prior methotrexate for non-cancerous conditions is allowed
Post-menopausal patients at breast cancer (BC) diagnosis, as determined locally
Diagnosis of other active malignancy; prior treated malignancies in addition to breast cancer are acceptable
Ever had a diagnosis of invasive or microinvasive breast cancer
Has a breast cancer recurrence, metastasis, or another interval cancer diagnosis following the breast cancer (excluding non-melanoma skin cancer)
New breast cancer diagnosis
Recent diagnosis of breast cancer with pending surgery as primary treatment for breast cancer
Confirmed first diagnosis of stage IV breast cancer or a recurrent diagnosis of metastatic breast cancer (MBC) (i.e., spread to distant organs), any time since diagnosis
Patient must be an Asian American who has had a breast cancer diagnosis in the past  years
Primary diagnosis of breast cancer (initial or recurrence) within the last two years
Have a diagnosis of stage I-III female breast cancer or colorectal cancer within the past  years; bilateral or multiple primary breast cancers are permitted; individuals who have had more than one type of cancer (e.g., both breast and melanoma) are permitted as long as the breast (or colorectal) diagnosis meets the other criteria and primary treatment for any cancer is not ongoing
YOUNG BREAST CANCER SURVIVORS (YBCS): Breast cancer (Stages -III) diagnosis
YBCS: Breast cancer diagnosis age ?  years
Patients who have a diagnosis of breast cancer
Patients with a recurrent breast cancer diagnosis
Have a previous diagnosis of breast cancer
Histologically confirmed stage I, II or III breast cancer (if the patient has had more than one breast cancer diagnosis, then the most recent diagnosis)
Primary diagnosis of breast cancer within the last three years
Diagnosis of metastatic breast cancer
Diagnosis of recurrent breast cancer
Diagnosis of breast cancer with adjuvant chemotherapy treatment
Diagnosis of breast cancer
Diagnosis of HER-positive breast cancer
History of a diagnosis of breast cancer
Breast cancer diagnosis within past  years
Have a confirmed diagnosis of breast cancer; participants can have had more than one primary cancer diagnosis in the past
Patients with known diagnosis of breast cancer
Have a prior diagnosis of T or T breast cancer diagnosed within the last  years
History of prior breast cancer treated within the past two years; patients completing all breast cancer-specific treatment over two years prior to the current diagnosis are eligible
COHORT B: No prior diagnosis of breast cancer but at high risk for development of breast cancer and participating in HSC 
Diagnosis of breast cancer
Previous history or current diagnosis of breast cancer
Patients with a previous diagnosis of invasive breast cancer who are less than  years from diagnosis
Life expectancy of at least  years, excluding diagnosis of breast cancer (comorbid conditions should be taken into consideration, but breast cancer diagnosis is not a consideration)
New diagnosis of breast cancer
New diagnosis if a previous breast cancer patient with negative surgical margins
Pathologic diagnosis of invasive breast cancer or high suspicion of breast cancer based on imaging
with a suspicious lesion found in the breast and recommended for biopsy or have a confirmed diagnosis of cancer;
Women who have undergone open surgical (excisional) biopsy for breast cancer diagnosis
Patients must have a current diagnosis of sarcoma, lymphoma, or HER(-) breast cancer
Patients with a prior breast cancer diagnosis
Patients must have a current diagnosis of breast cancer, non-small cell lung cancer, or colorectal cancer; the current diagnosis may be an initial diagnosis or recurrence and/or progression of previously diagnosed disease; cancer may be metastatic or non-metastatic
Diagnosis of invasive breast cancer
Pregnant at the time of diagnosis of their breast cancer.
Diagnosis of primary breast cancer.
Confirmed current or past diagnosis of invasive breast cancer
